-
Je něco špatně v tomto záznamu ?
Refining genotype-phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants
K. Burgmaier, L. Brinker, F. Erger, BB. Beck, MR. Benz, C. Bergmann, O. Boyer, L. Collard, C. Dafinger, M. Fila, C. Kowalewska, B. Lange-Sperandio, L. Massella, A. Mastrangelo, D. Mekahli, M. Miklaszewska, N. Ortiz-Bruechle, L. Patzer, L....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, pozorovací studie, práce podpořená grantem
NLK
Freely Accessible Science Journals
od 1972
Open Access Digital Library
od 1972-01-01
Elsevier Open Access Journals
od 2021-03-01 do 2021-03-31
Elsevier Open Access Journals
od 2021-10-01 do 2021-10-31
Elsevier Open Archive Journals
od 1972-01-01 do Před 4 lety
- MeSH
- dítě MeSH
- fenotyp MeSH
- genetické asociační studie MeSH
- ledviny MeSH
- lidé MeSH
- mutace MeSH
- polycystické ledviny autozomálně recesivní * diagnóza genetika MeSH
- předškolní dítě MeSH
- receptory buněčného povrchu genetika MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- předškolní dítě MeSH
- Publikační typ
- časopisecké články MeSH
- pozorovací studie MeSH
- práce podpořená grantem MeSH
Autosomal recessive polycystic kidney disease (ARPKD) is a severe disease of early childhood that is clinically characterized by fibrocystic changes of the kidneys and the liver. The main cause of ARPKD are variants in the PKHD1 gene encoding the large transmembrane protein fibrocystin. The mechanisms underlying the observed clinical heterogeneity in ARPKD remain incompletely understood, partly due to the fact that genotype-phenotype correlations have been limited to the association of biallelic null variants in PKHD1 with the most severe phenotypes. In this observational study we analyzed a deep clinical dataset of 304 patients with ARPKD from two independent cohorts and identified novel genotype-phenotype correlations during childhood and adolescence. Biallelic null variants frequently show severe courses. Additionally, our data suggest that the affected region in PKHD1 is important in determining the phenotype. Patients with two missense variants affecting amino acids 709-1837 of fibrocystin or a missense variant in this region and a null variant less frequently developed chronic kidney failure, and patients with missense variants affecting amino acids 1838-2624 showed better hepatic outcome. Variants affecting amino acids 2625-4074 of fibrocystin were associated with poorer hepatic outcome. Thus, our data expand the understanding of genotype-phenotype correlations in pediatric ARPKD patients and can lay the foundation for more precise and personalized counselling and treatment approaches.
Centro Materno Infantil do Norte Centro Hospitalar do Porto Porto Portugal
Department of Pediatric Nephrology Medical University of Lublin Lublin Poland
Department of Pediatric Nephrology University Hospitals Leuven Leuven Belgium
Department of Pediatrics Children's Hospital St Elisabeth and St Barbara Halle Germany
Department of Pediatrics Dr von Hauner Children's Hospital University Hospital LMU Munich Germany
Institute of Human Genetics RWTH University Hospital Aachen Aachen Germany
KfH Center of Pediatric Nephrology Children's Hospital Munich Schwabing Munich Germany
Medizinische Genetik Mainz Limbach Genetics Mainz Germany
Pediatric Nephrology Dachau Dachau Germany
Pediatric Nephrology Unit CHU Arnaud de Villeneuve Université de Montpellier Montpellier France
PKD Research Group Department of Development and Regeneration KU Leuven Leuven Belgium
Reference centre pediatric nephrology Clinique de l'Espérance Montegnee Belgium
Renal Division Department of Medicine University Freiburg Medical Center Freiburg Germany
University Children's Hospital University Medical Center Hamburg Eppendorf Hamburg Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21025040
- 003
- CZ-PrNML
- 005
- 20211026134200.0
- 007
- ta
- 008
- 211013s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.kint.2021.04.019 $2 doi
- 035 __
- $a (PubMed)33940108
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Burgmaier, Kathrin $u Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Rare Diseases, University Hospital Cologne and Medical Faculty, University of Cologne, Cologne, Germany
- 245 10
- $a Refining genotype-phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants / $c K. Burgmaier, L. Brinker, F. Erger, BB. Beck, MR. Benz, C. Bergmann, O. Boyer, L. Collard, C. Dafinger, M. Fila, C. Kowalewska, B. Lange-Sperandio, L. Massella, A. Mastrangelo, D. Mekahli, M. Miklaszewska, N. Ortiz-Bruechle, L. Patzer, L. Prikhodina, B. Ranchin, N. Ranguelov, R. Schild, T. Seeman, L. Sever, P. Sikora, M. Szczepanska, A. Teixeira, J. Thumfart, B. Uetz, LT. Weber, E. Wühl, K. Zerres, ESCAPE Study group, GPN study group, J. Dötsch, F. Schaefer, MC. Liebau, ARegPKD consortium
- 520 9_
- $a Autosomal recessive polycystic kidney disease (ARPKD) is a severe disease of early childhood that is clinically characterized by fibrocystic changes of the kidneys and the liver. The main cause of ARPKD are variants in the PKHD1 gene encoding the large transmembrane protein fibrocystin. The mechanisms underlying the observed clinical heterogeneity in ARPKD remain incompletely understood, partly due to the fact that genotype-phenotype correlations have been limited to the association of biallelic null variants in PKHD1 with the most severe phenotypes. In this observational study we analyzed a deep clinical dataset of 304 patients with ARPKD from two independent cohorts and identified novel genotype-phenotype correlations during childhood and adolescence. Biallelic null variants frequently show severe courses. Additionally, our data suggest that the affected region in PKHD1 is important in determining the phenotype. Patients with two missense variants affecting amino acids 709-1837 of fibrocystin or a missense variant in this region and a null variant less frequently developed chronic kidney failure, and patients with missense variants affecting amino acids 1838-2624 showed better hepatic outcome. Variants affecting amino acids 2625-4074 of fibrocystin were associated with poorer hepatic outcome. Thus, our data expand the understanding of genotype-phenotype correlations in pediatric ARPKD patients and can lay the foundation for more precise and personalized counselling and treatment approaches.
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a genetické asociační studie $7 D056726
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ledviny $7 D007668
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a fenotyp $7 D010641
- 650 12
- $a polycystické ledviny autozomálně recesivní $x diagnóza $x genetika $7 D017044
- 650 _2
- $a receptory buněčného povrchu $x genetika $7 D011956
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a pozorovací studie $7 D064888
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Brinker, Leonie $u Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany
- 700 1_
- $a Erger, Florian $u Center for Rare Diseases, University Hospital Cologne and Medical Faculty, University of Cologne, Cologne, Germany; Institute of Human Genetics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany
- 700 1_
- $a Beck, Bodo B $u Center for Rare Diseases, University Hospital Cologne and Medical Faculty, University of Cologne, Cologne, Germany; Institute of Human Genetics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany
- 700 1_
- $a Benz, Marcus R $u Pediatric Nephrology Dachau, Dachau, Germany
- 700 1_
- $a Bergmann, Carsten $u Medizinische Genetik Mainz, Limbach Genetics, Mainz, Germany; Renal Division, Department of Medicine, University Freiburg Medical Center, Freiburg, Germany
- 700 1_
- $a Boyer, Olivia $u Department of Pediatric Nephrology and Kidney Transplantation, Necker Hospital, APHP, Paris University, Paris, France
- 700 1_
- $a Collard, Laure $u Reference centre pediatric nephrology, Clinique de l'Espérance, Montegnee, Belgium
- 700 1_
- $a Dafinger, Claudia $u Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany
- 700 1_
- $a Fila, Marc $u Pediatric Nephrology Unit, CHU Arnaud de Villeneuve-Université de Montpellier, Montpellier, France
- 700 1_
- $a Kowalewska, Claudia $u Department of Nephrology, Kidney Transplantation and Hypertension, The Children's Memorial Health Institute, Warsaw, Poland
- 700 1_
- $a Lange-Sperandio, Bärbel $u Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU, Munich, Germany
- 700 1_
- $a Massella, Laura $u Division of Nephrology, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital - IRCCS, Rome, Italy
- 700 1_
- $a Mastrangelo, Antonio $u Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy
- 700 1_
- $a Mekahli, Djalila $u PKD Research Group, Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium
- 700 1_
- $a Miklaszewska, Monika $u Department of Pediatric Nephrology and Hypertension, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland
- 700 1_
- $a Ortiz-Bruechle, Nadina $u Institute of Human Genetics, RWTH University Hospital Aachen, Aachen, Germany
- 700 1_
- $a Patzer, Ludwig $u Department of Pediatrics, Children's Hospital St. Elisabeth and St. Barbara, Halle (Saale), Germany
- 700 1_
- $a Prikhodina, Larisa $u Department of Inherited and Acquired Kidney Diseases, Research Clinical Institute for Pediatrics n.a. acad. Y. E. Veltishev, Pirogov Russian National Research Medical University, Moscow, Russia
- 700 1_
- $a Ranchin, Bruno $u Pediatric Nephrology Unit, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Centre de référence maladies rénales rares, Bron, France
- 700 1_
- $a Ranguelov, Nadejda $u Department of Pediatrics, Université Catholique de Louvain Medical School, Saint-Luc Academic Hospital, Brussels, Belgium
- 700 1_
- $a Schild, Raphael $u University Children's Hospital, University Medical Center Hamburg Eppendorf, Hamburg, Germany
- 700 1_
- $a Seeman, Tomas $u Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU, Munich, Germany; Department of Pediatrics, University Hospital Motol, 2nd Faculty of Medicine, Charles University Prague, Prague, Czech Republic
- 700 1_
- $a Sever, Lale $u Department of Pediatric Nephrology, Cerrahpaşa School of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey
- 700 1_
- $a Sikora, Przemyslaw $u Department of Pediatric Nephrology, Medical University of Lublin, Lublin, Poland
- 700 1_
- $a Szczepanska, Maria $u Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
- 700 1_
- $a Teixeira, Ana $u Centro Materno-Infantil do Norte, Centro Hospitalar do Porto, Porto, Portugal
- 700 1_
- $a Thumfart, Julia $u Department of Pediatric Gastroenterology, Nephrology and Metabolic Diseases, Charité Universitätsmedizin Berlin, Berlin, Germany
- 700 1_
- $a Uetz, Barbara $u KfH Center of Pediatric Nephrology, Children's Hospital Munich Schwabing, Munich, Germany
- 700 1_
- $a Weber, Lutz Thorsten $u Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Rare Diseases, University Hospital Cologne and Medical Faculty, University of Cologne, Cologne, Germany
- 700 1_
- $a Wühl, Elke $u Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany
- 700 1_
- $a Zerres, Klaus $u Institute of Human Genetics, RWTH University Hospital Aachen, Aachen, Germany
- 700 1_
- $a Dötsch, Jörg $u Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Rare Diseases, University Hospital Cologne and Medical Faculty, University of Cologne, Cologne, Germany
- 700 1_
- $a Schaefer, Franz $u Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany
- 700 1_
- $a Liebau, Max Christoph $u Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Rare Diseases, University Hospital Cologne and Medical Faculty, University of Cologne, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany. Electronic address: max.liebau@uk-koeln.de
- 710 2_
- $a ESCAPE Study group
- 710 2_
- $a GPN study group
- 710 2_
- $a ARegPKD consortium
- 773 0_
- $w MED00010141 $t Kidney international $x 1523-1755 $g Roč. 100, č. 3 (2021), s. 650-659
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33940108 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026134206 $b ABA008
- 999 __
- $a ok $b bmc $g 1714201 $s 1145547
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 100 $c 3 $d 650-659 $e 20210430 $i 1523-1755 $m Kidney international $n Kidney Int $x MED00010141
- LZP __
- $a Pubmed-20211013